We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Reauthorizes Eli Lilly Antibodies for COVID-19, But Only in Certain States
FDA Reauthorizes Eli Lilly Antibodies for COVID-19, But Only in Certain States
The FDA has reissued its emergency use authorization (EUA) for Eli Lilly’s monoclonal antibodies bamlanivimab and etesevimab for treatment of COVID-19 — but only for certain states.